Effect of Black seed (Nigella Sativa) powder on diabetes

Effect of Black seed (Nigella Sativa) powder on serum glucose and Lipids level of type 2 diabetic patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170501033751N3

Enrollment

Registered

2019-05-07

Start date

2019-01-21

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group:Each capsule contains 500 milligrams of blackseed grains.One capsule per day orally(For two months) This capsule is manufactured by Institute of Medicinal Plants of

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age over 18 years and under 60 years; at least 6 months passed from diabetes diagnosis. The patient does not have adequate glycemic control

Exclusion criteria

Exclusion criteria: According to patients' statements, they suffer from any mental or physical illness and consume drugs; be pregnant

Design outcomes

Primary

Measure	Time frame
Blood glucose. Timepoint: Before the intervention and two months after starting the consume of Black seed (Nigella Sativa) powder. Method of measurement: Measurement of blood glucose level in the laboratory using an autoanalyzer.	—

Secondary

Measure	Time frame
Lipid profile. Timepoint: Before the intervention and two months after starting the consume of black seed powder. Method of measurement: Measurement of serum lipids levels in the laboratory using an autoanalyzer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRezvan Ghafarzadegan

Arak University of Medical Sciences

rghafarzadegan@gmail.com+98 86 4633 2211

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026